Daniel Stauder
Stock Analyst at Citizens
(4.28)
# 425
Out of 5,124 analysts
21
Total ratings
65%
Success rate
17.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STXS Stereotaxis | Initiates: Market Outperform | $4 | $2.30 | +73.91% | 1 | Dec 16, 2025 | |
| AORT Artivion | Maintains: Market Outperform | $47 → $53 | $45.61 | +16.20% | 7 | Nov 7, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $39.56 | +51.67% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $1.38 | +407.25% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $81.10 | +35.64% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $567.93 | +27.66% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $11.23 | - | 1 | May 7, 2024 |
Stereotaxis
Dec 16, 2025
Initiates: Market Outperform
Price Target: $4
Current: $2.30
Upside: +73.91%
Artivion
Nov 7, 2025
Maintains: Market Outperform
Price Target: $47 → $53
Current: $45.61
Upside: +16.20%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $39.56
Upside: +51.67%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $1.38
Upside: +407.25%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $81.10
Upside: +35.64%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $567.93
Upside: +27.66%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $11.23
Upside: -